Medistep Healthcare Peer Comparison

NSE: MEDISTEP

₹23.40

₹0.50 (2.18%)

As on 07-Sep-2026IST

Market cap

₹33 Cr

Revenue (TTM)

₹50 Cr

P/E Ratio

5.4

P/B Ratio

0.9

Div. Yield

0 %

Edit

	Medistep Healthcare	Entero Health	Bio Medica Laboratories	Speciality Medicines	VijayPD Ceutical
Market cap (₹ Cr)	33	8,143	223	130	123
Revenue (₹ Cr)	50	7,128	38	58	107
Net Profit (₹ Cr)	4.14	167.66	9.79	8.61	4.80
Net Margin (%)	8.35	2.35	25.56	14.70	4.46
RoE (%)	29.06	7.58	99.59	37.85	14.91
Price to Earnings	5.44	64.93	18.56	9.98	24.60
Price-To-Book	0.86	4.69	--	1.83	--

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Medistep Healthcare	Entero Health	Bio Medica Laboratories	Speciality Medicines	VijayPD Ceutical
Operating Revenue	49.65	5,095.78	38.20	58.27	106.81
Total Income	49.66	5,135.29	38.33	58.54	107.59
Total Expenditure	44.04	4,924.23	22.82	49.14	98.22
EBITDA	5.61	171.55	15.37	9.13	8.59
Depreciation	0.03	30.69	1.01	0.20	0.69
EBIT	5.58	140.86	14.37	8.93	7.90
Interest	0.04	41.62	1.35	0.51	2.15
Other Income	0.00	39.51	0.13	0.27	0.78
Exceptional Items	--	--	--	--	--
Profit before Tax	5.54	138.74	13.14	8.69	6.52
Provision for Tax	1.39	31.31	3.35	0.08	1.73
Profit after Tax	4.14	107.43	9.79	8.61	4.80

Liabilities (₹ Cr)

	Medistep Healthcare	Entero Health	Bio Medica Laboratories	Speciality Medicines	VijayPD Ceutical
Shareholder's Funds	16.83	1,724.15	14.73	30.42	32.17
Minority Interest	--	46.21	--	--	--
Non-Current Liabilities	0.01	72.84	7.17	2.77	0.47
Current Liabilities	6.13	845.02	16.99	6.80	24.46
Total Liabilities	22.99	2,702.52	39.12	39.98	57.15

Assets (₹ Cr)

	Medistep Healthcare	Entero Health	Bio Medica Laboratories	Speciality Medicines	VijayPD Ceutical
Non-Current Assets	0.13	612.51	7.81	3.56	10.70
Current Assets	22.85	2,075.71	31.09	36.42	46.40
Total Assets	22.99	2,702.52	39.12	39.98	57.15
Total Debt*	0.64	298.81	15.01	5.05	21.77
Net Current Assets	16.71	1,230.69	14.10	29.62	21.95
Contingent Liabilities	--	4.01	0.05	--	0.39

Cashflow (₹ Cr)

	Medistep Healthcare	Entero Health	Bio Medica Laboratories	Speciality Medicines	VijayPD Ceutical
Cash From Operating Activities	0.02	-76.87	-3.67	-5.79	-7.89
Cash Flow from Investing Activities	--	219.80	0.34	-2.07	-0.55
Cash from Financing Activities	1.28	-73.66	3.33	8.46	-2.38
Net Cash Inflow / Outflow	1.30	69.27	0.00	0.60	-10.82

Ratios

Profitability Ratios

	Medistep Healthcare	Entero Health	Bio Medica Laboratories	Speciality Medicines	VijayPD Ceutical
ROCE (%)	37.86	9.16	64.18	34.47	16.08
ROE (%)	29.06	6.40	99.59	37.85	14.91
ROA (%)	21.85	4.29	33.60	27.50	8.40
EBIT Margin (%)	11.31	4.14	40.59	16.13	8.77
Net Margin (%)	8.35	2.09	25.56	14.70	4.46
Cash Profit Margin (%)	8.41	2.71	28.28	15.11	5.14

Growth Ratios

	Medistep Healthcare	Entero Health	Bio Medica Laboratories	Speciality Medicines	VijayPD Ceutical
Revenue Growth (%)	57.06	29.92	150.47	111.71	0.00
EBIT Growth (%)	41.31	67.16	170.72	73.88	--
Net Profit Growth (%)	42.24	169.94	292.00	193.43	0.00
EPS Growth (%)	33.18	142.37	292.00	133.30	0.00
Book Value Growth (%)	44.00	5.11	198.35	101.92	0.00

Valuation Ratios

	Medistep Healthcare	Entero Health	Bio Medica Laboratories	Speciality Medicines	VijayPD Ceutical
Price / Earnings	0.00	52.15	0.00	0.00	0.00
Price / Book Value	0.00	2.88	0.00	0.00	0.00
Dividend Yield (%)	--	0.00	--	--	--
EV/EBITDA	1.74	23.61	1.56	1.13	3.49
Market Cap (₹ Cr)	0.00	4,944.94	0.00	0.00	0.00

Solvency Ratios

	Medistep Healthcare	Entero Health	Bio Medica Laboratories	Speciality Medicines	VijayPD Ceutical
Debt to Equity	0.04	0.17	1.02	0.17	0.68
Short term debt to equity ratio	0.04	0.17	0.43	0.04	0.64
Current Ratio	3.73	2.46	1.83	5.36	1.90
Quick Ratio	3.55	1.68	0.76	2.80	1.43
Interest Coverage	127.74	4.33	10.70	18.03	4.03

Operating Efficiency Ratios

	Medistep Healthcare	Entero Health	Bio Medica Laboratories	Speciality Medicines	VijayPD Ceutical
Debtors to sales (%)	40.51	16.30	10.73	16.45	22.28
Asset Turnover	2.62	2.03	1.31	1.86	1.87
Receivable days	124.47	51.78	30.75	63.57	81.32
Inventory Days	7.44	38.71	121.86	79.57	39.42
Payable days	16.20	24.83	117.74	14.65	8.63
Cash Conversion Cycle	115.71	65.66	34.88	128.49	112.12

Annual
Quarterly